Welcome to the e-CCO Library!

P783: Increased risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide population-based study
Year: 2018
Source: ECCO '18 Vienna
Authors:

E.A. Kang1*, J. Lee1, K. Han2, J. Kim1, J. Chun1, J.S. Kim1, J.P. Im1

Created: Thursday, 21 February 2019, 9:14 AM
P783: Long-term colectomy rate in acute severe ulcerative colitis. An observational multi-centre study on behalf of IG-IBD (Italian group for the study of inflammatory bowel disease)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Festa*1, M. L. Scribano2, D. Pugliese3, E. Sarli4, C. Bezzio5, M. B. Principi6, D. G. Ribaldone7, M. Allocca8, G. Mocci9, G. Bodini10, R. Spagnuolo11, P. Vernia12, S. Mazzuoli13, G. Laino14, B. Barberio15, G. Zerboni16, A. Aratari16, C. Papi16

Created: Friday, 22 February 2019, 9:41 AM
P783: Symptom Improvement of ulceRative colitis after an Injection dose of Ustekinumab in Japanese clinical practice, measured using patient-reported outcomes (SIRIUS) study, Interim Analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Matsuoka, K.(1)*;Katsumasa, N.(2);Murata, Y.(2);Hisamatsu, T.(3);
Created: Friday, 14 July 2023, 11:12 AM
P784 A new questionnaire to investigate patients’ knowledge of relevant aspects of inflammatory bowel disease clinical course and outcomes: preliminary results
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Zerboni1, S. Barello2, S. Festa3, A. Aratari3, G. Graffigna2, C. Papi3

Created: Thursday, 30 January 2020, 10:12 AM
P784: A comparison study of the mucosa-associated microbiota between inflamed and non-inflamed sites in ulcerative colitis patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Hirano A.*1, Umeno J.1, Shibata H.2, Kitazono T.1, Esaki M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P784: Prevalence of cervical dysplasia in women with inflammatory bowel disease: data from the Parelsnoer Institute (PSI) and PALGA database (PAP-IBD study)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Goetgebuer*1, J. Kreijne1, C. Aitken2, M. Pierik3, F. Hoentjen4, N. de Boer5, B. Oldenburg6, A. van der Meulen7, C. Ponsioen8, G. Dijkstra9, F. van Kemenade10, G. Nieuwenhuyzen – de Boer11, A. Siebers12, C. J. van der Woude1, A. de Vries1

Created: Friday, 22 February 2019, 9:41 AM
P784: Real-world use and 6-month effectiveness of vedolizumab subcutaneous in IBD patients: results of the VEDO-IBD study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Plachta-Danielzik, S.(1);Bokemeyer, B.(1,2,3)*;Efken, P.(4);Mohl, W.(5);Hoffstadt, M.(6);Krause, T.(7);Schweitzer, A.(8);Schnoy, E.(9);Ehehalt, R.(10);Trentmann, L.(11);Teich, N.(12);Atreya, R.(13);Franzenburg, S.(1);Hartmann, P.(4);Wenske, T.(1);Schreiber, S.(1,3);
Created: Friday, 14 July 2023, 11:12 AM
P784: The direct healthcare costs of Crohn’s disease increased over the last two decades in a Dutch population-based cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Lalisang1*, D. Wintjens1,2, M. Romberg-Camps3, A. van Bodegraven3, L. Oostenbrug3, J. Haans1, A. Masclee1,2, D. Jonkers1,2, M. Pierik1,2

Created: Thursday, 21 February 2019, 9:14 AM
P785 Predictors of mortality in IBD patients treated for pneumonia
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. Ukashi1,2, Y. Barash2,3,4, M.J. Segel2,5, B. Ungar1,2, S. Soffer2,3,4, S. Ben-Horin1,2, E. Klang2,3,4, U. Kopylov1,2

Created: Thursday, 30 January 2020, 10:12 AM
P785: A retrospective cohort study on vedolizumab trough levels in Crohn's disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pokryszka, J.(1)*;Stadlmann, M.(2);Primas, C.(3);Gerold, N.(3);Reinisch, S.(3);
Created: Friday, 14 July 2023, 11:12 AM
P785: Association of Bacteroidetes with endoscopic activity in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Baston I.*1, Sueiro R.2, Uribarri L.1, Ferreiro R.1, Leiro J.M.2, Dominguez-Munoz J.E.1, Barreiro-de Acosta M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P785: Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Kemos1*, M. Aardoom2, F. Ruemmele3, L. de Ridder2, N. Croft1, on behalf of the PIBD SETQuality consortium and PIBDnet

Created: Thursday, 21 February 2019, 9:14 AM
P785: The prevalence of inflammatory bowel disease doubled in the last decade in Israel: an epiIIRN national population-based study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Friedman1,2, D. Navon1, N. Asayag1, G. Focht1, I. Brufman3, B. Feldman3, A. Cahan4, N. Ledderman5, E. Matz6, Y. Chowers7, R. Eliakim8, S. Ben-Horin8, S. Odes9, D. Schwartz9, I. Dotan10, E. Israeli11, R. D. Balicer3, D. Turner*1, Israeli IBD Research Nucleus (IIRN)1

Created: Friday, 22 February 2019, 9:41 AM
P786 Non-alcoholic fatty liver disease among patients with inflammatory bowel disease in Qatar: Prevalence and risk factors
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Almohannadi1, P. Chandra2, B. Varughese1, A. Darweesh3, A. Hamid1, A. Badi1, S.A. Kaabi1, R. Yakoob1, K. Al-Ejji1, K. Sultan1, N. Abunahia1, M. Ameer Hamza Shah3, M. Derbala1

Created: Thursday, 30 January 2020, 10:12 AM
P786: Correlation between the presence of Bacteroidetes and faecal calprotectin for the detection of endoscopic activity in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Baston I.*1, Sueiro R.2, Ferreiro R.1, Uribarri L.1, Leiro J.M.2, Dominguez-Munoz J.E.1, Barreiro-de Acosta M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P786: Induction of endoscopic response, remission and ulcer-free endoscopy with upadacitinib is associated with improved clinical outcomes in patients with Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Panés, J.(1)*;Louis, E.(2);Bossuyt, P.(3);Joshi, N.(4);Lee, W.J.(4);Lacerda, A.(4);Remple, V.(4);Xuan, S.(4);Loftus Jr. , E.V.(5);
Created: Friday, 14 July 2023, 11:12 AM
P786: Mode of delivery and risk of inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Frias Gomes*1, N. Narula2, B. Morão1, P. Nicola3, M. Cravo1, J. Torres1

Created: Friday, 22 February 2019, 9:41 AM
P786: The use and escalation of treatments in patients with inflammatory bowel disease; a 10 years follow-up of a Danish population-based inception cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Lo1*, I. Vind1, F. Bendtsen1, M. Vester-Andersen1,2, J. Burisch1

Created: Thursday, 21 February 2019, 9:14 AM
P787 Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicentre study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Mocci1, M. Demurtas2, F.M. Onidi1, M. Picchio3, W. Elisei4, R. Manca5, F. Miculan2, C. Mais2, P. Usai6, F. Chicco6, M.A. Lai6, S. Magrì6, L. Binaghi1, M.F. Dore1, M.P. Dore7, B.Q. Colosso7, L. Cugia8, M. Carta8, R. Pisanu8, M. Marzo9, M.L. Porcedda10, M. Argiolas10, F. Cabras1, A. Armuzzi11

Created: Thursday, 30 January 2020, 10:12 AM
P787: Impact of inflammatory bowel disease on working life: A French nationwide survey
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Gonzalez1,2*, A. Buisson3, A. Olympie3, M.-H. Ravel3, C. Bienenfeld4, L. Peyrin-Biroulet5

Created: Thursday, 21 February 2019, 9:14 AM